Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,364,874
+$206,877 QoQ
Shares Held
8,709
+14.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#532
of 1,603 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BRIGHTON JONES LLC holds $86,570,928 across 13 Drug Manufacturers - General names. NVS ranks #10 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
17,958 | $21,539,365 | |
| 2 | JNJ |
Johnson & Johnson
|
57,725 | $14,660,418 | |
| 3 | AMGN |
Amgen Inc
|
34,281 | $12,413,835 | |
| 4 | MRK |
Merck & Co., Inc.
|
90,183 | $11,588,515 | |
| 5 | ABBV |
AbbVie Inc.
|
33,304 | $8,380,618 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
122,001 | $7,029,697 | |
| 7 | PFE |
Pfizer Inc
|
155,516 | $3,744,825 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
18,796 | $2,374,686 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,364,874 | 8,709 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,157,997 | 7,581 | Shares | Sole | 2026-08-07 | |
| 2025-09-30 | $856,514 | 6,679 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $726,302 | 6,002 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $669,660 | 6,007 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $598,748 | 6,153 | Shares | Sole | 2025-03-04 | |
| 2024-09-30 | $401,074 | 3,487 | Shares | Sole | 2025-03-04 | |
| 2024-06-30 | $574,777 | 5,399 | Shares | Sole | 2025-03-04 | |
| 2024-03-31 | $474,363 | 4,904 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $469,813 | 4,653 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $473,241 | 4,646 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $455,810 | 4,517 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $377,476 | 4,103 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $368,051 | 4,057 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $380,962 | 5,012 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $390,359 | 4,618 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $447,349 | 5,098 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $440,586 | 5,037 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $429,263 | 5,249 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $372,715 | 4,085 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $326,191 | 3,816 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $382,063 | 4,046 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $349,057 | 4,014 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $209,965 | 2,404 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $287,832 | 3,491 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||